These experiments revealed that CDG regulated gut microbiota dysbiosis in MPTP-induced PD mice, reduced neuroinflammation, and induced neuroprotective effects via suppressing TLR4/NF-κB pathway, offering fresh perspectives for more intensive research. The gene discussed is TLR4; the disease is Parkinson disease.